MeSH tree: G06.920
A new study from the University of Gothenburg may help guide the development of better influenza vaccines. Memory cells in the nose slow the influenza virus as soon as it enters the body. They reduce viral levels and may ...
Apr 12, 2026
0
10
Dengue, a mosquito-borne disease, affects millions of people every year across Asia, Africa and Latin America. And it's expanding geographically as warmer temperatures and urban growth allow mosquito populations to thrive ...
Mar 25, 2026
0
8
In a new study published in Nature, University of Minnesota researchers have found that the Marburg virus, one of the world's deadliest pathogens with an average 73% fatality rate, is unusually efficient at getting inside ...
Mar 11, 2026
0
9
Researchers at the University of Jyväskylä (Finland), in cooperation with national and international research groups, have shown that DNA viruses infect cells and take over the host cell nucleus, inducing dramatic structural ...
Feb 7, 2026
0
8
A single 40-mg dose of the antiviral drug suraxavir marboxil significantly shortened flu symptom resolution time in male patients aged 5–65, according to research led by the China-Japan Friendship Hospital in China. Intriguingly, ...
Using hypertonic saline nasal drops can reduce the length of the common cold in children by two days, according to a study that will be presented at the European Respiratory Society (ERS) Congress in Vienna, Austria. They ...
Sep 5, 2024
0
54
Important differences in how the nasal cells of young and elderly people respond to the SARS-CoV-2 virus, could explain why children typically experience milder COVID-19 symptoms, finds a new study led by researchers at UCL ...
Apr 15, 2024
0
94
With new cases, hospitalizations and mortality rates holding steady in many parts of the world, University of Georgia researchers have developed a faster detection technique for COVID-19.
Apr 4, 2024
0
62
Published in the Journal of Infectious Diseases, new research led by the University of Minnesota Medical School offers a new avenue of hope in the fight against chronic human immunodeficiency virus (HIV) infection.
Feb 14, 2024
0
136
For adults with mild-to-moderate COVID-19, early administration of simnotrelvir plus ritonavir shortens the time to sustained resolution of symptoms, according to a study published in the Jan. 18 issue of the New England ...
Jan 18, 2024
0
29
